Literature DB >> 9532735

Photobactericidal activity of phenothiazinium dyes against methicillin-resistant strains of Staphylococcus aureus.

M Wainwright1, D A Phoenix, S L Laycock, D R Wareing, P A Wright.   

Abstract

The photodynamic antibacterial properties of a closely related series of phenothiazinium dyes were tested against several pathogenic strains of Staphylococcus aureus, four of which were methicillin-resistant. Illumination of the photosensitisers at a fluence rate of 1.75 mW cm-2 generally resulted in the enhancement of antibacterial activity in liquid culture and in greater efficacy than the methicillin analogue flucloxacillin. For methylene blue, dimethyl methylene blue and new methylene blue illumination led to increases in bactericidal activity < or = 16-fold, typically 4-fold. In addition dimethyl methylene blue and new methylene blue were active against epidemic strains of methicillin-resistant Staphylococcus aureus at concentrations lower than that of vancomycin (> or = 0.5 microM).

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9532735     DOI: 10.1111/j.1574-6968.1998.tb12908.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  48 in total

1.  Blue dye and red light, a dynamic combination for prophylaxis and treatment of cutaneous Candida albicans infections in mice.

Authors:  Tianhong Dai; Vida J Bil de Arce; George P Tegos; Michael R Hamblin
Journal:  Antimicrob Agents Chemother       Date:  2011-09-19       Impact factor: 5.191

2.  Photodynamic therapy: a new antimicrobial approach to infectious disease?

Authors:  Michael R Hamblin; Tayyaba Hasan
Journal:  Photochem Photobiol Sci       Date:  2004-02-12       Impact factor: 3.982

3.  Targeted photodynamic therapy of established soft-tissue infections in mice.

Authors:  Faten Gad; Touqir Zahra; Kevin P Francis; Tayyaba Hasan; Michael R Hamblin
Journal:  Photochem Photobiol Sci       Date:  2004-02-11       Impact factor: 3.982

4.  Effects of growth phase and extracellular slime on photodynamic inactivation of gram-positive pathogenic bacteria.

Authors:  Faten Gad; Touqir Zahra; Tayyaba Hasan; Michael R Hamblin
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

Review 5.  Photodynamic therapy targeted to pathogens.

Authors:  T N Demidova; M R Hamblin
Journal:  Int J Immunopathol Pharmacol       Date:  2004 Sep-Dec       Impact factor: 3.219

6.  Antimicrobial photodynamic therapy treatment of chronic recurrent sinusitis biofilms.

Authors:  Merrill A Biel; Chet Sievert; Marina Usacheva; Matthew Teichert; Jim Balcom
Journal:  Int Forum Allergy Rhinol       Date:  2011-08-18       Impact factor: 3.858

7.  Phenothiazinium antimicrobial photosensitizers are substrates of bacterial multidrug resistance pumps.

Authors:  George P Tegos; Michael R Hamblin
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

8.  Antimicrobial blue light therapy for multidrug-resistant Acinetobacter baumannii infection in a mouse burn model: implications for prophylaxis and treatment of combat-related wound infections.

Authors:  Yunsong Zhang; Yingbo Zhu; Asheesh Gupta; Yingying Huang; Clinton K Murray; Mark S Vrahas; Margaret E Sherwood; David G Baer; Michael R Hamblin; Tianhong Dai
Journal:  J Infect Dis       Date:  2013-12-30       Impact factor: 5.226

9.  Susceptibility of Staphylococcus aureus to porphyrin-mediated photodynamic antimicrobial chemotherapy: an in vitro study.

Authors:  Mariana M Gois; Christina Kurachi; E J B Santana; E G O Mima; D M P Spolidório; José Eduardo Pelizon Pelino; Vanderlei Salvador Bagnato
Journal:  Lasers Med Sci       Date:  2009-07-08       Impact factor: 3.161

10.  Inhibitors of bacterial multidrug efflux pumps potentiate antimicrobial photoinactivation.

Authors:  George P Tegos; Kayo Masago; Fatima Aziz; Andrew Higginbotham; Frank R Stermitz; Michael R Hamblin
Journal:  Antimicrob Agents Chemother       Date:  2008-05-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.